GGrantIndex
← Leaderboards

Peiqing Sun

Scripps Research Institute

$10,120,095
Attributed
$10,120,095
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200518
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$10,120,095 · 4

By mechanism

R01$10,120,095 · 4

Top collaborators

No co-investigators on record.

Most similar at Scripps Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Tumor Suppression

Research focus

Tumor SuppressionInsightOncogenicSenescenceTumorMediatingTumorigenesisOncogenesMalignant NeoplasmsSkin CarcinogenesisCancer ModelIn VivoPhosphotransferasesPlayResponseDesignMutationPathway InteractionsMap Kinase GeneRegulationLeadCellsMapk14 GeneTumor Suppressor Proteins

Grant awards (32)

Role of Tip60 in Oncogene-Induced Senescence and Tumor Suppression$348,750
R01 · FY2018 · CA · contact PI
The role of microRNA in oncogene-induced senescence and cancer development$321,625
R01 · FY2018 · CA · contact PI
Role of Tip60 in Oncogene-Induced Senescence and Tumor Suppression$348,750
R01 · FY2017 · CA · contact PI
The role of microRNA in oncogene-induced senescence and cancer development$321,625
R01 · FY2017 · CA · contact PI
Role of Tip60 in Oncogene-Induced Senescence and Tumor Suppression$348,750
R01 · FY2016 · CA · contact PI
The role of microRNA in oncogene-induced senescence and cancer development$321,625
R01 · FY2016 · CA · contact PI
Role of Tip60 in Oncogene-Induced Senescence and Tumor Suppression$243,137
R01 · FY2015 · CA · contact PI
The role of microRNA in oncogene-induced senescence and cancer development$204,368
R01 · FY2015 · CA · contact PI
The role of microRNA in oncogene-induced senescence and cancer development$188,845
R01 · FY2015 · CA · contact PI
Role of Tip60 in Oncogene-Induced Senescence and Tumor Suppression$183,238
R01 · FY2015 · CA · contact PI
Role of Tip60 in Oncogene-Induced Senescence and Tumor Suppression$426,375
R01 · FY2014 · CA · contact PI
The role of microRNA in oncogene-induced senescence and cancer development$393,213
R01 · FY2014 · CA · contact PI
P38 MAPK in Ras-induced Senescence and Transformation$267,732
R01 · FY2014 · CA · contact PI
P38 MAPK in Ras-induced Senescence and Transformation$42,442
R01 · FY2014 · CA · contact PI
P38 MAPK in Ras-induced Senescence and Transformation$300,581
R01 · FY2013 · CA · contact PI
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression$382,221
R01 · FY2012 · CA · contact PI
P38 MAPK in Ras-induced Senescence and Transformation$319,767
R01 · FY2012 · CA · contact PI
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression$382,221
R01 · FY2011 · CA · contact PI
P38 MAPK in Ras-induced Senescence and Transformation$319,767
R01 · FY2011 · CA · contact PI
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression$394,043
R01 · FY2010 · CA · contact PI
P38 MAPK in Ras-induced Senescence and Transformation$329,657
R01 · FY2010 · CA · contact PI
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression$394,043
R01 · FY2009 · CA · contact PI
p38 MAPK in Ras-induced Senescence and Transformation$319,381
R01 · FY2009 · CA · contact PI
p38 MAPK in Ras-induced Senescence and Transformation$319,381
R01 · FY2008 · CA · contact PI
p38 MAPK in Ras-induced Senescence and Transformation$358,441
R01 · FY2007 · CA · contact PI
p38 MAPK in Ras-induced Senescence and Transformation$369,147
R01 · FY2006 · CA · contact PI
p53-independent Role of MDM2, TGFb Resistance and Cancer$321,909
R01 · FY2006 · CA · contact PI
p38 MAPK in Ras-induced Senescence and Transformation$330,437
R01 · FY2005 · CA
p53-independent Role of MDM2, TGFb Resistance and Cancer$329,656
R01 · FY2005 · CA
p53-independent Role of MDM2, TGFb Resistance and Cancer$329,656
R01 · FY2004 · CA
p53-independent Role of MDM2, TGFb Resistance and Cancer$329,656
R01 · FY2003 · CA
p53-independent Role of MDM2, TGFb Resistance and Cancer$329,656
R01 · FY2002 · CA